Gene & Drug Delivery for Retinal Diseases: What is Next? (Controlled Release Society)

Course Organiser: F. Behar-Cohen SWITZERLAND

 

A. Urtti FINLAND
Posterior segment pharmokinetics

R. Herrero-Vanrell SPAIN
Microparticles as therapeutic tools in retinal diseases

E. Stefánsson ICELAND
Cyclodextrin nanoparticle eye drops for retinal diseases

F. Behar-Cohen SWITZERLAND
Viral / non-viral gene delivery for retinal diseases

Roundtable discussion
– Is intravitreous route optimal to target chorio-retinal diseases?
– Can we reduce drug doses and maintain long-term effects?
– What are the obstacles for clinical use of particulate systems?
– The place of gene therapy in clinical practice

 

End of session

Back

Want to find out more about EURETINA activities?

Contact us
© EURETINA All rights reserved